RFP - Comparative Study of IPA-implementing vis-à-vis Non-implementing Facilities in Meghalaya
Issued by Health Systems Transformation Platform (HSTP) · via DevNetJobs India — RFP & Assignments
- Published
- 11 Nov 2026
- Closes
- 20 Nov 2026
- Reference
- devnet-307052
- Location
- Meghalaya, India
- Sector
- Healthcare & Pharma
- Type
- consultancy
At a glance
Health Systems Transformation Platform (HSTP) in India has published a request for proposals in healthcare & pharma: “RFP - Comparative Study of IPA-implementing vis-à-vis Non-implementing Facilities in Meghalaya”. Submissions close on 20 November 2026, 9 days from today. Quote reference devnet-307052 in any correspondence with the buyer. FreeTender has recorded 4 notices from this buyer since 2026, 2 of them currently open. There are 551 open healthcare & pharma notices in India on FreeTender. Bids are submitted to the buyer through DevNetJobs India — RFP & Assignments, not through FreeTender.
Details
Request for Proposals
Comparative Study of IPA-implementing vis-à-vis Non-implementing Facilities in Meghalaya
Terms of Reference
Issued by the Forum for Health Systems Design and Transformation Health Systems Transformation Platform (HSTP)
Study focus: Assessment of current Outcome-Based Budgeting implementation, patient experience and community outreach in Meghalaya.
RFP schedule
Date and time
Issue date
10.11.2026
Deadline for queries
16.11.2026
Proposal submission deadline
20.11.2026
1 About HSTP
The Forum for Health Systems Design and Transformation, popularly known as the Health Systems Transformation Platform (HSTP), is a not-for-profit company registered under Section 8 of the Indian Companies Act, 2013, and established under the aegis of Tata Trusts. HSTP works with governments and other partners to generate and apply evidence for stronger, more equitable and responsive health systems through research, technical assistance and implementation support.
HSTP invites proposals from qualified research organisations, academic institutions and consulting agencies to assess the implementation of Internal Performance Agreement (IPA) now known as Outcome-Based Budgeting (OBB) in Meghalaya guided by the principle of results-based financing, with patient exit interviews and community outreach assessment as the principal components.
2 Background and rationale
Meghalaya’s experience with Internal Performance Agreements (IPA) in selected health facilities informed the introduction of OBB in December 2025 and the subsequent transition of facilities across the state. OBB links financing with performance and seeks to strengthen local decision-making, accountability, service quality and responsiveness to community needs.
With facilities now operating under OBB, an IPA versus non-IPA comparison is no longer appropriate. Asking patients or community members to reconstruct their experiences from the earlier IPA period would also introduce substantial recall bias. The study will therefore assess current OBB implementation and service performance, without a historical comparison of a control group.
Patient exit interviews will capture the care received during the current visit. Community assessment will examine recent outreach, access barriers and unmet need, including the experiences of people who do not attend facilities. Facility and financial records will help explain how resources and implementation practices relate to these experiences and identify priorities for improvement.
3 Study objectives
3.1 Overall objective
To assess current OBB implementation in Meghalaya and how funded activities address patient and community needs, with particular emphasis on patient experience, affordability, effective outreach and equitable access to care.
3.2 Specific objectives
Assess patients’ experiences of access, respectful care, communication, medicine and diagnostic availability, out-of-pocket expenditure, and advice on referral and follow-up during their current facility visit.
Assess the reach, regularity and responsiveness of community outreach, its links to service uptake and continuity of care, and barriers affecting underserved populations and non-users.
Examine current OBB fund flows, resource utilisation, facility autonomy, accountability and implementation constraints in relation to patient services and outreach.
Document community participation, provider and manager experiences, operational practices and service gaps that require attention.
Develop actionable recommendations to strengthen OBB implementation, monitoring and sustainable health financing in Meghalaya, with lessons relevant to other states.
Proposal submission
Submit separate technical and financial proposals electronically in Word format by the deadline notified by HSTP. The technical proposal shall include:
Organisation and investigator details; executive summary; understanding of the assignment; design, sampling justification, tools and analysis plan.
Quality assurance, ethics and data-management arrangements; work plan; deliverables; team CVs and responsibilities; relevant assignments and conflict-of-interest declaration.
The financial proposal shall follow Section 11. HSTP may seek clarifications, discuss the proposed approach and verify relevant experience before selection. Late or incomplete proposals may not be considered.
Designated contact
Dr. Nishikant Singh
Lead Health Financing & Planning
Health Systems Transformation Platform, New Delhi
Email: nishikant.singh@hstp.org.in
All proposals must be submitted @ hstp@hstp.org.in by 20 th November 2026. Late submissions will not be considered.
For detailed information, please check the complete version of the RFP attached below.
Context for bidders
We hold 4 notices from Health Systems Transformation Platform (HSTP), going back to October 2026 — 2 of them still open. There are 551 open Healthcare & Pharma tenders in India. This one closes in 9 days.
More from this buyer
- RFP - Evaluation of the Leadership Development Program· closes 22 Nov
Similar Healthcare & Pharma tenders
- RFP - Evaluation of the Leadership Development Program· closes 22 Nov
- Supply of PVMS No 010931, Tab Methylcobalamine 1500 mcg· closes 8 Dec
- Supply of PVMS No 011133, Rosuvastatin 5mg Tab· closes 8 Dec
- Supply of PVMS No 013282, Acyclovir 800mg Tab· closes 8 Dec
- Supply of PVMS No 011653, Anti-Haemorrhoidal Ointment Containing Betamethasone 0.025 percent, Phenylephrine 0.1 percent and Lignocaine 2.5 percent, Tube of 20 gm with Applicator· closes 8 Dec
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Who won similar contracts
Recent contract awards in India, from published award notices.
- Engagement of a Consultant to conduct Cumulative Impact Assessment for the Kolkata Metropolitan Area West Bengal Inland Water Transport Logistic and Spatial Development Project (WBIWTLSDP)-2nd CallWon by SMEC International PTY LTD (India) · INR 14,883,000.00 · 14 Sept 2026
- Project Management and Technical Consultant (PMTC) to provide specialized engineering, advisory and implementation support to the PIU housed in HPJSV Shimla and FIU at different zones for the effectivWon by TATA Consulting Engineers (tce) Limited (India) · INR 449,786,711.00 · 25 Aug 2026
More Healthcare & Pharma tenders
- Поставка лекарственного препарата Амикацин, раствор для инфузий и внутримышечного введения и/или раствор для внутривенного и внутримышечного введения, 250 мг/мл, 2 мл и/или порошок для приготовления раствора для внутривенного и внутримышечного введения и/или лиофилизат для приготовления раствора для внутривенного и внутримышечного введения, 500 мг в рамках реализации постановления Правительства РоФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
- Поставка лекарственного препарата Моксифлоксацин, таблетки, покрытые пленочной оболочкой, 400 мг в рамках реализации постановления Правительства Российской Федерации от 28.12.2016 № 1512 «Об утверждении Положения об организации обеспечения лиц, инфицированных вирусом иммунодефицита человека, в том числе в сочетании с вирусами гепатитов В и С, антивирусными лекарственными препаратами для медицинскоФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
- Поставка расходных материалов для ЦКДЛМИНИСТЕРСТВО ИМУЩЕСТВЕННЫХ И ЗЕМЕЛЬНЫХ ОТНОШЕНИЙ ВЛАДИМИРСКОЙ ОБЛАСТИ · Russia
- Поставка реагентов для автоматического биохимического анализатора BS-240ProГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ПЕРМСКОГО КРАЯ "КУНГУРСКАЯ БОЛЬНИЦА" · Russia
- Поставка канюлей для искусственного кровообращения артериальнойФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →